Stocks Health care OBX
NASDAQ · Health careObsidian Therapeutics, Inc. (OBX)
At June 30, 2026 it held $0 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
What Obsidian Therapeutics, Inc. does
Obsidian Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OBX.
Latest SEC filings
What Obsidian Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026IPO registration S-1
- August 14, 2026Exhibits 8-K/A
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026
- August 11, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Passive stake (5% or more) SCHEDULE 13G
- August 3, 2026
- August 3, 2026
- August 3, 2026Form 8-A12B/A filing 8-A12B/A
Questions about OBX
What does Obsidian Therapeutics, Inc. do?
Obsidian Therapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OBX.
When did Obsidian Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the iPO registration from August 28, 2026.
Similar companies
Follow OBX
Get an email when Obsidian Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow OBX: get an email when it filesWhere the numbers come from
Financial figures are the values Obsidian Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.